Water-Soluble Cu(II) Complexes with Polypyridyl Ligands: Anticancer Activity and DNA Interaction
Authors:
- Herisson F. dos SantosHSHerisson F. dos Santos
- Nádija N. P. da SilvaNSNádija N. P. da Silva
- George B. S. PereiraGPGeorge B. S. Pereira
- Mauro A. LimaMLMauro A. Lima
- Nailton M. Nascimento-JúniorNNNailton M. Nascimento-Júnior
- Renan L. de FariasRenan L. de Farias
- Amos O. AkinyemiAAAmos O. Akinyemi
- Fillipe V. RochaFRFillipe V. Rocha
Open Access
- 19 February 2025
- journal article
- research article
- Published by MDPI AG in Future Pharmacology
- Vol. 5 (1) , 10
Abstract
Background/Objectives: Cu(II) complexes with polypyridine ligands have shown carcinogenic activity already described in the literature and appear as a possible alternative to cisplatin, which has several side effects. In view of this, four Cu(II) complexes with the formulas [Cu(L1)(H2O)2](PF6)2 (A1) and [Cu(L2)(H2O)2](PF6)2 (A2), [Cu(L1)(bipy)](PF6)2 (B1) and [Cu(L2)(bipy)](PF6)2 (B2) were synthesized, where L1 = dipyrido[1,2,5]oxadiazolo[3,4-b]quinoxaline, L2 = 6,7-dicyanodipyrido[2,2-d:2,3-f]quinoxaline, and bipy = 2,2′-bipyridine. Methods: The proposed structures supported characterization techniques (molar conductivity, elemental analyses, absorption spectroscopy in the infrared region, and UV–vis). The interaction of the complexes with DNA was evaluated through an ethidium bromide displacement assay, complemented by theoretical studies using molecular docking. Additionally, the cytotoxic activity of the complexes was tested against DU 145 (prostate tumor), MCF-7 (breast tumor), and PNT-2 (non-tumor prostate) cell lines, with all complexes showing promising results. Results: Among them, complex B1 exhibited the highest number of DNA contacts in molecular docking studies, a binding constant of 3.7 × 106 in the ethidium bromide displacement assay. It was the most selective complex (IS = 5.43) for the DU 145 (prostate tumor) cell line, demonstrating greater selectivity than cisplatin. Conclusions: This study has demonstrated the potential of the Cu(II) complexes obtained, which could be an alternative to platinum complexes in the futureKeywords
Funding Information
- National Council for Scientific and Technological Development (CNPq-401681/2023-8, 01.22.0182, 2019/11242-1, 2022/02876-0, 2018/00187-7)
- Coordination for the Improvement of Higher Education Personnel (CAPES) (CNPq-401681/2023-8, 01.22.0182, 2019/11242-1, 2022/02876-0, 2018/00187-7)
- FINEP (CNPq-401681/2023-8, 01.22.0182, 2019/11242-1, 2022/02876-0, 2018/00187-7)
- São Paulo State Research Foundation (FAPESP) (CNPq-401681/2023-8, 01.22.0182, 2019/11242-1, 2022/02876-0, 2018/00187-7)
This publication has 28 references indexed in Scilit:
- Copper and Copper Complexes in Tumor TherapyChemMedChem, 2024
- Copper pyrazole complexes as potential anticancer agents: Evaluation of cytotoxic response against cancer cells and their mechanistic action at the molecular levelCoordination Chemistry Reviews, 2023
- Copper in cancer: From pathogenesis to therapyBiomedicine & Pharmacotherapy, 2023
- Ruthenium Complexes as Potential Cancer Cell Growth Inhibitors for Targeted ChemotherapyChemistrySelect, 2022
- DNA-interacting properties of two analogous square-planar cis-chlorido complexes: copper versus palladiumJBIC Journal of Biological Inorganic Chemistry, 2021
- In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological targetEuropean Journal of Medicinal Chemistry, 2020
- Interactions of copper complexes with nucleic acidsCoordination Chemistry Reviews, 2018
- Software for molecular docking: a reviewBiophysical Reviews, 2017
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Towards improving compound selection in structure-based virtual screeningDrug Discovery Today, 2008